Please do not send any confidential information to us. By clicking “Accept,” you acknowledge and agree that our review of the information in your email and any attachments does not establish an attorney-client relationship between you and our firm or any of our attorneys, and does not preclude our representation of other persons/parties in matters where the information is pertinent, even if the information is highly confidential or could be exploited to your disadvantage, or you submitted it in good faith to retain us.
This website uses cookies to improve your browsing experience. By continuing to use this website you agree to our use of cookies. For more information on our use of cookies, click here to review the Cookies Policy.。
TY focuses his practice on Intellectual Property Rights protection, licensing, enforcement, litigation; unfair competition and other legal areas dealing with Intellectual Property Rights. TY has many years of experience in attacking the heavy volume of counterfeit drugs. His quality is recognized by major pharmaceutical companies which include Abbott, AstraZeneca, Eli Lilly, GSK, Haw Par, Mentholatum, Merck, Pfizer, Roche, Sanofi-Aventis and Wyeth etc. Such devotion stems from their appreciation of his quality, efficiency, and understanding of their needs.
Educational Background
LL.M., University of California at Berkeley School of Law/Boalt Hall (2000)
National Chengchi University (1988)
Practices
Pharmaceuticals products protection; Intellectual Property Rights protection, licensing, enforcement, litigation; unfair competition and other legal areas dealing with; Intellectual Property Rights
Experience
Lecturer - Taiwan Police College
Qualifications
Patent Attorney (1993) Attorney-at-Law (1992)
Language
Mandarin, English
Publications
2016
Taiwan Seeks to Join TPP with Draft Pharma Law Amendments World Intellectual Property Report Vol.30. No.4
